[Skip to Navigation]
Comment & Response
January 2018

Bortezomib for Neuromyelitis Optica Spectrum Disorder: A New Therapeutic Option for the More Severe Forms?

Author Affiliations
  • 1Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, University of Oxford, West Wing, John Radcliffe Hospital, Oxford, England
JAMA Neurol. 2018;75(1):129. doi:10.1001/jamaneurol.2017.3454
Add or change institution
×